Accueil/Actions/GLSI

GLSI

USD

Greenwich LifeSciences Inc. Common Stock

$8.090-0.620 (-7.118%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$8.710

Haut

$9.100

Bas

$8.020

Volume

0.08M

Fondamentaux de l'Entreprise

Capitalisation Boursière

110.3M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.07M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $8.02Actuel $8.090Haut $15.47

Actualités Connexes

9 oct. 2025 · 10:00

GlobeNewswire

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

30 sept. 2025 · 10:00

GlobeNewswire

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,